Summary:
- The FDA is using an artificial intelligence (AI) system to help review and approve new drug applications more efficiently.
- However, there are concerns that the AI system may be generating fake or misleading study data to support drug approvals, which could put public health at risk.
- Experts are calling for more transparency and oversight of the FDA's use of AI in the drug approval process to ensure the integrity and reliability of the data being used.